ad

Nifty Pharma Prediction for Tomorrow, Wednesday 8 July 2026: Index Slips 0.73 Percent to 25,677.70 Against a Rising Market

Nifty Pharma prediction for tomorrow, Wednesday 8 July 2026: close 25,677.70, -0.73%. Day range 25,645.90 to 26,022.75. Support 25,645. Resistance 25,875.


7 Jul 20264:08 pm

Nifty Pharma Prediction for Tomorrow, Wednesday 8 July 2026: Index Slips 0.73 Percent to 25,677.70 Against a Rising Market

The nifty pharma prediction for tomorrow, Wednesday 8 July 2026, is cautious after the Nifty Pharma index closed at 25,677.70 today, Tuesday 7 July 2026, down 188.55 points or 0.73 percent, within a day range of 25,645.90 to 26,022.75. Today’s boundaries and constituent moves frame the nifty pharma prediction for tomorrow.

Ankit Jaiswal, Senior Research Analyst at Univest, and Kunal Singla, Associate Director at Univest, have shared their nifty pharma prediction for tomorrow for Wednesday 8 July 2026 using today’s closing data and global cues.

Click Here – Get Free Investment Predictions

Today’s Session Recap Behind the Nifty Pharma Prediction for Tomorrow

  • Sector session: The index opened at 25,874.40, touched a high of 26,022.75 and a low of 25,645.90, and closed at 25,677.70 against a previous close of 25,866.25. Among constituents, today’s intraday high of 26,022.75 marked a fresh 52 week high for the index before profit booking set in, with Sun Pharma, Cipla and Dr Reddy’s all giving up early gains.
  • In the broader market, the Nifty 50 closed at 24,398.70, down 0.13 percent, the Sensex ended at 78,180.72, down 0.13 percent, and the Bank Nifty slipped 0.16 percent to 58,200.70. A sharp IT sector rally could not offset weakness elsewhere: ICICI Bank fell 0.86 percent and Reliance Industries dropped 0.98 percent, while HDFC Bank closed nearly flat. India VIX eased to a fresh multi month low of 11.65, and FIIs bought Rs 1,355.33 crore in Friday’s cash session against DII selling of Rs 1,953.89 crore; Monday and today’s figures are awaited.

Key Levels in the Nifty Pharma Prediction for Tomorrow

Trend: Cautious, watch for stabilisation. Support levels: 25,645 and 25,500. Resistance levels: 25,875 and 26,025.

For the nifty pharma prediction for tomorrow, today’s low makes 25,645 the first support, with 25,500 below it. Resistance sits at 25,875, near today’s high, and then 26,025. The 52 week range of 21,149.90 to 26,022.75 provides the wider context. A close back above 25,875 is needed to neutralise todays weakness.

Key Drivers Shaping the Nifty Pharma Prediction for Tomorrow

  • Fresh 52 week high followed by pullback: The index touched 26,022.75 intraday, its best level in a year, before easing 0.73 percent by the close on profit booking.
  • Export and biosimilar optimism intact: US generic pricing stability and biosimilar pipelines continue to support the medium term earnings outlook.
  • Defensive rotation away today: With IT rallying sharply, some rotation out of pharma into technology names likely added to the pullback.

Index Data and Derivatives Snapshot

The snapshot below captures today’s index data for the sector:

Metric Value
Close 25,677.70
Change -188.55 points (-0.73%)
Open 25,874.40
Day High 26,022.75
Day Low 25,645.90
Previous Close 25,866.25
52 Week High 26,022.75
52 Week Low 21,149.90

Derivatives view: Sun Pharma, Cipla and Dr Reddy’s stock futures are among the liquid pharma contracts, and their F&O positioning guides the sector since the pharma index has no derivatives of its own.

Explore SEBI Registered Investment Advisory on Univest

Trading Strategy for Tomorrow

  • Wait for stabilisation above 25,875: Fresh longs are better timed after the index reclaims 25,875 or defends 25,645 convincingly.
  • Track the leaders: Constituent heavyweights drive this basket; follow their stock futures flows for intraday confirmation.
  • Respect the invalidation: A close below 25,500 would deepen the corrective phase for Tuesday.
  • Mind the fresh weekly cycle: Today was the Nifty 50 weekly options expiry, so tomorrow opens an entirely new weekly cycle with reset positioning.

What Does Sentiment Indicate for the Nifty Pharma Prediction for Tomorrow?

Sentiment in the nifty pharma prediction for tomorrow reflects today’s relative performance. Ankit Jaiswal notes that the sector underperformed on a day when the broader market itself closed lower, and such relative weakness usually needs a specific trigger to reverse.

Kunal Singla observes that with India VIX at 11.65, a fresh multi month low, and FIIs net buyers in Friday’s cash session, the market backdrop limits downside contagion, so stabilisation above 25,645 could attract rotation buyers in the nifty pharma prediction for tomorrow.

Risks to the Nifty Pharma Prediction for Tomorrow

  • US session tonight: Wall Street’s first full trading week after last week’s holiday, concluding tonight, can reset the opening tone for all sectors tomorrow.
  • Fresh cycle volatility: Today’s Nifty weekly expiry has settled, and early positioning in tomorrow’s new weekly cycle can bring added swings.
  • Constituent concentration: A reversal in the basket’s heaviest stocks can swing the index beyond the stated levels.
  • Earnings season repricing: Q1 FY27 results starting this week can reset sector expectations quickly.

Download the Univest iOS App or Univest Android App to track live sector index levels and get daily predictions.

Conclusion: Nifty Pharma Prediction for Tomorrow

The nifty pharma prediction for tomorrow, Wednesday 8 July 2026, from Univest analysts Ankit Jaiswal and Kunal Singla is cautious with a stabilisation first approach. The index closed at 25,677.70 (-0.73 percent) and is expected to trade between 25,645 and 26,025, with 25,500 as the invalidation level below which weakness deepens. Constituent stock futures flows and tomorrow’s fresh weekly cycle are the factors to track. Check back after tomorrow’s close for the next nifty pharma prediction update from Univest analysts.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

FAQs on the Nifty Pharma Prediction for Tomorrow

What is the nifty pharma prediction for tomorrow, Wednesday 8 July 2026?

Ans. The nifty pharma prediction for tomorrow, Wednesday 8 July 2026, is cautious. The index closed at 25,677.70 today, down 0.73 percent, and is expected to trade in a 25,645 to 26,025 range with support at 25,645 and 25,500 and resistance at 25,875 and 26,025.

What are the key levels in the nifty pharma prediction for tomorrow?

Ans. For the nifty pharma prediction for tomorrow, immediate support is at 25,645, near today’s low of 25,645.90, followed by 25,500. Resistance sits at 25,875, near today’s high of 26,022.75, and then 26,025.

Which stocks drive the nifty pharma prediction for tomorrow?

Ans. Constituent moves shape the nifty pharma prediction for tomorrow. Today, today’s intraday high of 26,022.75 marked a fresh 52 week high for the index before profit booking set in, with Sun Pharma, Cipla and Dr Reddy’s all giving up early gains.

Does the index have futures and options for the nifty pharma prediction for tomorrow?

Ans. Sun Pharma, Cipla and Dr Reddy’s stock futures are among the liquid pharma contracts, and their F&O positioning guides the sector since the pharma index has no derivatives of its own.

How does today’s Nifty expiry affect the nifty pharma prediction for tomorrow?

Ans. Tuesday 7 July 2026 was the Nifty 50 weekly options expiry, which settled at today’s close. Tomorrow opens an entirely fresh weekly cycle with reset open interest, so early positioning is worth watching for the nifty pharma prediction for tomorrow.

Is the nifty pharma prediction for tomorrow investment advice?

Ans. No. The nifty pharma prediction for tomorrow is educational content only. All levels are analyst observations, not recommendations. Univest is a SEBI registered research analyst (INH000013776) and readers should consult a SEBI registered advisor before acting on any view.

Recent Articles

Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.

Reviews

user-review-1
user-review-2
user-review-3
user-review-4
user-review-5

RESEARCH ANALYST

Get SEBI Registered
advice on the stocks
trending today.

Get 3 FREE Trade Ideas

+91
for Startups Accelerator 2024

for Startups Accelerator 2024

Trusted by 1Cr Indians

Trusted by 1Cr Indians

Awarded No.1 by Economic Times

Awarded No.1 by Economic Times

GET THE APP

Join 1Cr users today.

SEBI Registered Analyst-backed Picks. Free Demat. One App

  • Free Demat account in under 5 minutes
  • Live market data — Nifty, Sensex, sector insights
  • SEBI Registered analyst-backed stock picks
Get it on Google PlayDownload on the App Store

Copyright 2026 Univest. All rights reserved.
Designed with ❤️ in India

arrow down